Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism

被引：0
作者：
Hui-Yan Shi
Jin Yan
Wen-Hui Zhu
Guo-Ping Yang
Zhi-Rong Tan
Wei-Hua Wu
Gan Zhou
Xiao-Ping Chen
Dong-Sheng Ouyang
机构：
[1] Central South University,Pharmacogenetics Research Institute, Institute of Clinical Pharmacology
[2] Central South University,Third Xiangya Hospital
[3] Central South University,Department of Pharmacology, School of Pharmaceutical Science
来源：
European Journal of Clinical Pharmacology | 2010年 / 66卷
关键词：
Voriconazole; Erythromycin; CYP2C19; Genetic polymorphism; Chinese;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1131 / 1136
页数：5
相关论文
共 50 条
  • [31] CYP2C19 polymorphism influences Helicobacter pylori eradication
    Kuo, Chao-Hung
    Lu, Chien-Yu
    Shih, Hsiang-Yao
    Liu, Chung-Jung
    Wu, Meng-Chieh
    Hu, Huang-Ming
    Hsu, Wen-Hung
    Yu, Fang-Jung
    Wu, Deng-Chyang
    Kuo, Fu-Chen
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (43) : 16029 - 16036
  • [32] Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects
    Kang, Pureum
    Cho, Chang-Keun
    Jang, Choon-Gon
    Lee, Seok-Yong
    Lee, Yun Jeong
    Choi, Chang-Ik
    Bae, Jung-Woo
    ARCHIVES OF PHARMACAL RESEARCH, 2023, 46 (05) : 438 - 447
  • [33] The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects
    Bo Tan
    Yi-Fan Zhang
    Xiao-Yan Chen
    Xiao-Hua Zhao
    Guo-Xin Li
    Da-Fang Zhong
    European Journal of Clinical Pharmacology, 2010, 66 : 145 - 151
  • [34] Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects
    Pureum Kang
    Chang-Keun Cho
    Choon-Gon Jang
    Seok-Yong Lee
    Yun Jeong Lee
    Chang-Ik Choi
    Jung-Woo Bae
    Archives of Pharmacal Research, 2023, 46 : 438 - 447
  • [35] The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects
    Tan, Bo
    Zhang, Yi-Fan
    Chen, Xiao-Yan
    Zhao, Xiao-Hua
    Li, Guo-Xin
    Zhong, Da-Fang
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (02) : 145 - 151
  • [36] Analysis of Combined Effect of CYP2C19 Genetic Polymorphism and Proton Pump Inhibitors Coadministration on Trough Concentration of Voriconazole
    Mafuru, Magesa
    Wu, Sanlan
    Mayala, Henry
    Msengwa, Zaituni
    Phillip, Amani
    Mgone, Charles
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2021, 14 : 1379 - 1389
  • [37] CYP2C19 polymorphism effect on phenobarbitone - Pharmacokineties in Japanese patients with epilepsy: analysis by population pharmacokinetics
    Mamiya, K
    Hadama, A
    Yukawa, E
    Ieiri, I
    Otsubo, K
    Ninomiya, H
    Tashiro, N
    Higuchi, S
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 55 (11-12) : 821 - 825
  • [38] CYP2C19 polymorphism effect on phenobarbitone Pharmacokineties in Japanese patients with epilepsy: analysis by population pharmacokinetics
    K. Mamiya
    A. Hadama
    E. Yukawa
    I. Ieiri
    K. Otsubo
    H. Ninomiya
    N. Tashiro
    S. Higuchi
    European Journal of Clinical Pharmacology, 2000, 55 : 821 - 825
  • [39] Influence of CYP2C19 genetic polymorphism and its ethnic distribution on concentration target attainment for voriconazole: a simulation study
    Goutelle, S.
    Tod, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 72 - 72
  • [40] Impact of CYP2C19 genotype on voriconazole exposure and effect of voriconazole on the activity of CYP3A in patients with haematological malignancies
    Huang, Fengru
    Zhou, Chen
    Zhang, Xiao-Yan
    Shen, Miss Ye
    Zhang, Hongwen
    Wang, Yongqing
    Sun, Luning
    XENOBIOTICA, 2021, 51 (10) : 1199 - 1206
12345